Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive monitoring of disease progression. This webinar will explore how Twist Bioscience’s customizable genomic solutions—including DNA/RNA panels, cfDNA/cfRNA liquid biopsy workflows, and innovative methylation detection systems—support research across the oncology journey. Through real-world case studies in pediatric cancer profiling, colorectal cancer screening, and minimal residual disease detection, attendees will learn how to apply scalable, cost-effective, and high-performance NGS tools to accelerate discoveries and advance precision oncology.

Learning Objectives:

1. Understand how custom NGS panels, liquid biopsy assays, and methylation profiling can improve cancer detection, monitoring, and biomarker discovery.

2. Explore case studies demonstrating the application of advanced genomic technologies in pediatric cancer research, colorectal cancer screening, and minimal residual disease detection.